Prediction modelling of inpatient neonatal mortality in high-mortality settings.
mortality
neonatology
Journal
Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434
Informations de publication
Date de publication:
22 Oct 2020
22 Oct 2020
Historique:
received:
27
03
2020
revised:
02
08
2020
accepted:
05
09
2020
entrez:
23
10
2020
pubmed:
24
10
2020
medline:
24
10
2020
Statut:
aheadofprint
Résumé
Prognostic models aid clinical decision making and evaluation of hospital performance. Existing neonatal prognostic models typically use physiological measures that are often not available, such as pulse oximetry values, in routine practice in low-resource settings. We aimed to develop and validate two novel models to predict all cause in-hospital mortality following neonatal unit admission in a low-resource, high-mortality setting. We used basic, routine clinical data recorded by duty clinicians at the time of admission to derive (n=5427) and validate (n=1627) two novel models to predict in-hospital mortality. The Neonatal Essential Treatment Score (NETS) included treatments prescribed at the time of admission while the Score for Essential Neonatal Symptoms and Signs (SENSS) used basic clinical signs. Logistic regression was used, and performance was evaluated using discrimination and calibration. At derivation, c-statistic (discrimination) for NETS was 0.92 (95% CI 0.90 to 0.93) and that for SENSS was 0.91 (95% CI 0.89 to 0.93). At external (temporal) validation, NETS had a c-statistic of 0.89 (95% CI 0.86 to 0.92) and SENSS 0.89 (95% CI 0.84 to 0.93). The calibration intercept for NETS was -0.72 (95% CI -0.96 to -0.49) and that for SENSS was -0.33 (95% CI -0.56 to -0.11). Using routine neonatal data in a low-resource setting, we found that it is possible to predict in-hospital mortality using either treatments or signs and symptoms. Further validation of these models may support their use in treatment decisions and for case-mix adjustment to help understand performance variation across hospitals.
Identifiants
pubmed: 33093041
pii: archdischild-2020-319217
doi: 10.1136/archdischild-2020-319217
pmc: PMC8070601
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 092654
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 097170
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Lancet Child Adolesc Health. 2020 Apr;4(4):299-311
pubmed: 32119841
Health Res Policy Syst. 2017 Feb 2;15(1):4
pubmed: 28153020
J Pediatr. 2008 Oct;153(4):519-24
pubmed: 18539298
Lancet Glob Health. 2019 Jun;7(6):e710-e720
pubmed: 31097275
Lancet. 2014 Jul 26;384(9940):347-70
pubmed: 24853604
BMJ Glob Health. 2016 May 24;1(1):e000028
pubmed: 27398232
J Clin Epidemiol. 2016 Aug;76:175-82
pubmed: 26964707
PLoS Med. 2013;10(2):e1001381
pubmed: 23393430
Arch Dis Child. 2015 Jan;100(1):42-7
pubmed: 25138104
J Clin Epidemiol. 2008 Nov;61(11):1085-94
pubmed: 19208371
Ann Intern Med. 2015 Jan 6;162(1):55-63
pubmed: 25560714
BMJ Glob Health. 2018 Sep 19;3(5):e001027
pubmed: 30258654
Syst Rev. 2017 Dec 07;6(1):248
pubmed: 29212522
J Am Med Inform Assoc. 2016 Jan;23(1):184-92
pubmed: 26063746
BMJ. 2012 May 24;344:e3186
pubmed: 22628131
Wellcome Open Res. 2019 Jun 17;4:96
pubmed: 31289756
Glob Health Action. 2014 Jul 31;7:24859
pubmed: 25084834
Eur Heart J. 2014 Aug 1;35(29):1925-31
pubmed: 24898551
Int J Epidemiol. 2019 Feb 1;48(1):186-198
pubmed: 30325465
Arch Dis Child. 2011 Nov;96(11):1052-9
pubmed: 21220263
PLoS Med. 2019 Dec 31;16(12):e1002987
pubmed: 31891572
Arch Dis Child Fetal Neonatal Ed. 2008 Mar;93(2):F80-2
pubmed: 17893122